ATE452141T1 - Neue proteine, z.b. zur verwendung für die in- vitro-isolierung und prävention von legionella pneumophila-infektionen - Google Patents
Neue proteine, z.b. zur verwendung für die in- vitro-isolierung und prävention von legionella pneumophila-infektionenInfo
- Publication number
- ATE452141T1 ATE452141T1 AT05778855T AT05778855T ATE452141T1 AT E452141 T1 ATE452141 T1 AT E452141T1 AT 05778855 T AT05778855 T AT 05778855T AT 05778855 T AT05778855 T AT 05778855T AT E452141 T1 ATE452141 T1 AT E452141T1
- Authority
- AT
- Austria
- Prior art keywords
- legionella pneumophila
- prevention
- polynucleotides
- new proteins
- vitro isolation
- Prior art date
Links
- 238000000338 in vitro Methods 0.000 title abstract 2
- 208000007764 Legionnaires' Disease Diseases 0.000 title 1
- 238000002955 isolation Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 abstract 4
- 108091033319 polynucleotide Proteins 0.000 abstract 4
- 239000002157 polynucleotide Substances 0.000 abstract 4
- 239000013604 expression vector Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241000589242 Legionella pneumophila Species 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 229940115932 legionella pneumophila Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0408714A FR2874025B1 (fr) | 2004-08-06 | 2004-08-06 | Nouvelles proteines permettant, notamment, la mise en evidence in vitro et la prevention des infections a legionella pneumophila |
| PCT/FR2005/001549 WO2006027431A1 (fr) | 2004-08-06 | 2005-06-21 | Nouvelles proteines permettant, notamment, la mise en evidence in vitro et la prevention des infections a legionella pneumophila |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE452141T1 true ATE452141T1 (de) | 2010-01-15 |
Family
ID=34949347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05778855T ATE452141T1 (de) | 2004-08-06 | 2005-06-21 | Neue proteine, z.b. zur verwendung für die in- vitro-isolierung und prävention von legionella pneumophila-infektionen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7704697B2 (de) |
| EP (1) | EP1781691B1 (de) |
| AT (1) | ATE452141T1 (de) |
| CA (1) | CA2576241A1 (de) |
| DE (1) | DE602005018369D1 (de) |
| FR (1) | FR2874025B1 (de) |
| WO (1) | WO2006027431A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2895519B1 (fr) * | 2005-12-28 | 2008-12-19 | Abag Sa | Utilisation de la proteine 5e2 dans le diagnostic in vitro d'infection a legionella pneumophila |
| FR2930646B1 (fr) * | 2008-04-29 | 2012-09-07 | Abag | Detection, in vitro, d'anticorps produits a la suite d'une infection a legionella pneumophila |
| US8785145B2 (en) | 2011-08-11 | 2014-07-22 | Ingen Biosciences | Method for diagnosing gram-negative infections |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| FR2862659B1 (fr) * | 2003-11-21 | 2006-02-10 | Pasteur Institut | Genome de legionella pneumophila souche paris- applications diagnostiques et epidemiologiques |
-
2004
- 2004-08-06 FR FR0408714A patent/FR2874025B1/fr not_active Expired - Fee Related
-
2005
- 2005-06-21 AT AT05778855T patent/ATE452141T1/de not_active IP Right Cessation
- 2005-06-21 CA CA002576241A patent/CA2576241A1/fr not_active Abandoned
- 2005-06-21 EP EP05778855A patent/EP1781691B1/de not_active Expired - Lifetime
- 2005-06-21 US US11/659,334 patent/US7704697B2/en not_active Expired - Fee Related
- 2005-06-21 WO PCT/FR2005/001549 patent/WO2006027431A1/fr active Application Filing
- 2005-06-21 DE DE602005018369T patent/DE602005018369D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1781691B1 (de) | 2009-12-16 |
| CA2576241A1 (fr) | 2006-03-16 |
| US20080260767A1 (en) | 2008-10-23 |
| FR2874025B1 (fr) | 2006-10-27 |
| EP1781691A1 (de) | 2007-05-09 |
| FR2874025A1 (fr) | 2006-02-10 |
| US7704697B2 (en) | 2010-04-27 |
| WO2006027431A1 (fr) | 2006-03-16 |
| DE602005018369D1 (de) | 2010-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ591415A (en) | Haemophilus influenzae type B | |
| MX348154B (es) | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. | |
| MX2008001865A (es) | Proteinas de fusion de albumina. | |
| WO2007064917A3 (en) | Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins | |
| MX2009002816A (es) | Proteinas de fusion de albumina. | |
| EA200901430A1 (ru) | Варианты фермента аспарагиназы и их применение | |
| TW201129379A (en) | Anti-Orai1 antigen binding proteins and uses thereof | |
| DK2027152T3 (da) | Peptidfragmenter til induktion af syntese af ekstracellulære matrixproteiner | |
| ATE417595T1 (de) | Keratin-bindende polypeptide | |
| NZ595063A (en) | Polypeptides from neisseria meningitidis | |
| NO20063026L (no) | Antistoffer | |
| MX2008009886A (es) | Anticuerpos que enlazan par-2. | |
| ATE519842T1 (de) | Trichoderma reesei-glucoamylase und homologe davon | |
| MX2010003055A (es) | Nuevas citocinas aviares y secuencias geneticas que las codifican. | |
| WO2008052173A8 (en) | Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use | |
| MX2012000133A (es) | Quimera de adn polimerasa del fago phi29. | |
| WO2006097432A3 (de) | Keratin-biktdende desmoplakinpolypeptidsequenzen | |
| ATE452141T1 (de) | Neue proteine, z.b. zur verwendung für die in- vitro-isolierung und prävention von legionella pneumophila-infektionen | |
| DK1913020T3 (da) | Immunogene konstrukter | |
| DE602007010969D1 (de) | Zytokinderivate | |
| ATE441865T1 (de) | Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila | |
| PL374550A1 (en) | Il-17 like molecules and uses thereof | |
| NZ589743A (en) | Anxiolytic composition containing alphas1-casein-derived peptides | |
| WO2009083968A8 (en) | Novel protein | |
| GB0409559D0 (en) | Polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |